ストックスクリーナーアプリを入手
56.85
0.16%
-0.0958
前日終値:
$56.75
開ける：
$56.64
24時間の取引高:
27,018
Relative Volume:
0.01
時価総額：
$10.91B
収益：
$2.95B
当期純損益:
$523.88M
株価収益率:
21.13
EPS:
2.69
ネットキャッシュフロー:
$620.18M
1週間 パフォーマンス:
-2.76%
1か月 パフォーマンス:
-8.51%
6か月 パフォーマンス:
-20.41%
1年 パフォーマンス:
-33.44%
1日の値動き範囲:
$56.58
$56.96
1週間の範囲:
$55.99
$59.79
52週間の値動き範囲:
$52.93
$86.04
Biomarin Pharmaceutical Inc Stock (BMRN) Company Profile
名前
Biomarin Pharmaceutical Inc
セクター
電話
(415) 506-6700
住所
105 DIGITAL DRIVE, NOVATO, CA
BMRN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BMRN
Biomarin Pharmaceutical Inc
|
56.80 | 10.90B | 2.95B | 523.88M | 620.18M | 2.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.43 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.77 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
566.75 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
740.29 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
338.67 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Biomarin Pharmaceutical Inc Stock (BMRN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-02-24 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-10-30 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-08-20 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-05-17 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-05-14 | 開始されました | Evercore ISI | Outperform |
| 2023-11-15 | 開始されました | Wells Fargo | Overweight |
| 2023-10-23 | アップグレード | Bernstein | Underperform → Mkt Perform |
| 2023-09-28 | 開始されました | Raymond James | Mkt Perform |
| 2023-09-18 | 開始されました | UBS | Buy |
| 2023-07-27 | 開始されました | Scotiabank | Sector Perform |
| 2023-07-05 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-06-14 | 再開されました | Credit Suisse | Outperform |
| 2023-03-21 | 開始されました | Bernstein | Underperform |
| 2023-02-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2023-02-21 | 開始されました | Citigroup | Neutral |
| 2023-01-30 | 開始されました | BMO Capital Markets | Market Perform |
| 2023-01-18 | 開始されました | Canaccord Genuity | Hold |
| 2022-10-31 | アップグレード | Oppenheimer | Perform → Outperform |
| 2022-07-13 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-06-13 | 再開されました | Wedbush | Neutral |
| 2022-04-25 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-22 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2021-10-07 | 再開されました | Jefferies | Buy |
| 2021-09-09 | アップグレード | Stifel | Hold → Buy |
| 2021-06-04 | 再開されました | Robert W. Baird | Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-03-04 | 再開されました | Guggenheim | Buy |
| 2021-03-01 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-08-20 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-08-20 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2020-08-19 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2020-08-19 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-08-19 | ダウングレード | Stifel | Buy → Hold |
| 2020-07-08 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-07-06 | 繰り返されました | Citigroup | Buy |
| 2020-01-28 | 開始されました | BMO Capital Markets | Market Perform |
| 2020-01-27 | 開始されました | BMO Capital Markets | Market Perform |
| 2020-01-24 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-27 | アップグレード | Barclays | Equal Weight → Overweight |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-10-17 | 再開されました | BofA/Merrill | Buy |
| 2019-05-23 | 再開されました | Citigroup | Buy |
| 2019-04-09 | 再開されました | Raymond James | Outperform |
| 2019-01-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2018-12-14 | 開始されました | Wolfe Research | Outperform |
| 2018-10-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-08-07 | 繰り返されました | Stifel | Buy |
| 2018-08-03 | 繰り返されました | Stifel | Buy |
すべてを表示
Biomarin Pharmaceutical Inc (BMRN) 最新ニュース
BioMarin Pharmaceutical Inc. stock daily chart insightsJuly 2025 WrapUp & Daily Profit Focused Stock Screening - Newser
BioMarin at Wells Fargo Conference: Strategic Focus on Rare Diseases - Investing.com
What machine learning models say about BioMarin Pharmaceutical Inc.Earnings Risk Summary & High Accuracy Buy Signal Tips - Newser
Will BioMarin Pharmaceutical Inc. bounce back from current supportJuly 2025 Action & Community Consensus Picks - Newser
Is BioMarin Pharmaceutical Inc. stock influenced by commodity pricesCEO Change & Risk Controlled Daily Trade Plans - khodrobank.com
Visual trend scoring systems applied to BioMarin Pharmaceutical Inc.2025 Year in Review & Technical Confirmation Trade Alerts - Newser
Technical signs of recovery in BioMarin Pharmaceutical Inc.July 2025 Closing Moves & Free Safe Entry Trade Signal Reports - Newser
Will BioMarin Pharmaceutical Inc. price bounce be sustainableMarket Performance Recap & Real-Time Sentiment Analysis - Newser
What’s the outlook for BioMarin Pharmaceutical Inc.’s sector2025 Price Targets & Free Community Supported Trade Ideas - khodrobank.com
Top chart patterns to watch in BioMarin Pharmaceutical Inc.Take Profit & Risk Adjusted Buy/Sell Alerts - Newser
Tick level data insight on BioMarin Pharmaceutical Inc. volatilityEarnings Trend Report & Capital Efficient Trade Techniques - Newser
What Does Wall Street Think About BioMarin Pharmaceutical (BMRN)? - MSN
BioMarin Pharmaceutical shares fall 1.15% after-hours following analyst presentation at Cantor Global. - AInvest
BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
BioMarin’s Strategic Position in the 2025 Healthcare Innovation Landscape - AInvest
Will BioMarin Pharmaceutical Inc. outperform small cap indexesPortfolio Update Report & Stock Market Timing Techniques - khodrobank.com
Can you recover from losses in BioMarin Pharmaceutical Inc.2025 AllTime Highs & Safe Capital Growth Trade Ideas - Newser
What makes BioMarin Pharmaceutical Inc. stock price move sharplyQuarterly Profit Review & Entry Point Confirmation Signals - Newser
Intraday pattern recognizer results for BioMarin Pharmaceutical Inc.2025 Top Decliners & Verified Swing Trading Watchlist - Newser
Analyzing drawdowns of BioMarin Pharmaceutical Inc. with statistical toolsPortfolio Profit Report & Stock Market Timing Techniques - Newser
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed? - 富途牛牛
Should I invest in BioMarin Pharmaceutical Inc. before earningsTrade Risk Assessment & AI Forecast Swing Trade Picks - khodrobank.com
Combining price and volume data for BioMarin Pharmaceutical Inc.Weekly Trend Summary & Risk Managed Investment Strategies - Newser
Applying Wyckoff theory to BioMarin Pharmaceutical Inc. stockWeekly Gains Report & Real-Time Market Sentiment Alerts - Newser
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock - au.finance.yahoo.com
Should you wait for a breakout in BioMarin Pharmaceutical Inc.Trade Analysis Summary & AI Optimized Trade Strategies - Newser
Can you recover from losses in BioMarin Pharmaceutical IncJuly 2025 Volume & Real-Time Stock Price Movement Reports - Newser
What moving averages say about BioMarin Pharmaceutical Inc.2025 Bull vs Bear & Expert-Curated Trade Recommendations - Newser
Identifying reversal signals in BioMarin Pharmaceutical Inc.July 2025 Institutional & Weekly Top Performers Watchlists - Newser
How to use a screener to detect BioMarin Pharmaceutical Inc. breakoutsWeekly Profit Report & Fast Moving Market Watchlists - Newser
Is BioMarin Pharmaceutical Inc. stock poised for growthMarket Growth Summary & Weekly Setup with High ROI Potential - Newser
Elliott Wave Theory Predicts Pullback in BioMarin Pharmaceutical Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
BioMarin Pharmaceutical's Short Interest Falls 3.68% Amid Market Sentiment Shift - AInvest
Should I set a stop loss on BioMarin Pharmaceutical Inc.July 2025 Sector Moves & Free Reliable Trade Execution Plans - sundaytimes.kr
Technical signs of recovery in BioMarin Pharmaceutical IncMarket Sentiment Review & Weekly Consistent Profit Watchlists - Newser
Bernstein Maintains a Buy Rating on BioMarin Pharmaceutical (BMRN) - MSN
Watch for Bullish Crossover in BioMarin Pharmaceutical Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
Biomarin Pharmaceutical Inc (BMRN) 財務データ
収益
当期純利益
現金流量
EPS
0.23%
大文字化:
|
ボリューム (24 時間):